Rappta Therapeutics (Rappta), focused to creating first-in-class anti-cancer therapies that activate protein phosphatase 2A (PP2A), has announced a global exclusive licensing agreement with SpringWorks Therapeutics (SpringWorks) for RPT04402...
Hikma Pharmaceuticals PLC, the global pharmaceutical company, has formed an exclusive commercial alliance with Emergent BioSolutions for marketing KLOXXADO naloxone HCl nasal spray 8 mg in the U.S. and Canada. KLOXXADO received approval from the...
Sumek Gopal, Head - Human Resources, India Region, Danaher, in an exclusive interview with India Pharma Outlook, shares his views on the adaptations that Indian organizations are making in their leadership development strategies, metrics and KPIs...
AI technology is set to greatly reduce research and development expenses in pharmaceuticals by streamlining drug discovery, enhancing clinical trials, and utilizing predictive data analytics, as per GlobalData survey. The leading data and...
Telix Pharmaceuticals Limited has announced that it has signed an asset purchase agreement with antibody engineering firm ImaginAb, Inc. (ImaginAb) to obtain a pipeline of next-generation therapeutic candidates, an innovative proprietary biologics...
Gilead Sciences, Inc. and LEO Pharma announced a strategic alliance aimed at speeding up the development and marketing of LEO Pharma’s small molecule oral STAT6 (signal transducer and activator of transcription 6) initiatives for the possible...
Increased investment in public healthcare, incentives for research and development, and tax breaks for additional life-saving medications are among the key demands of executives in the pharmaceutical and hospital sectors as they approach the...
US pharmaceutical giant Eli Lilly and Company announced that it intends to set up a new global capability center in Hyderabad. The organization plans to hire over 1,000 to 1,500 highly skilled individuals, including technology engineers and data...
Helen Critchley, Country Regulatory Head – Australia & NZ, Sanofi, at a session of the Asia Regulatory Conference, shared the importance of universal labeling and e-labeling in promoting digital transformation and global harmonization...
Novo Nordisk A/S and Valo Health, Inc. announced they have established a broader agreement to research and develop novel treatments for obesity, type 2 diabetes, and cardiovascular disease, utilizing Valo’s vast human dataset and AI-driven...
, CDSCO.jpg)
